Ongoing / Future Trials


An overarching study for children and adults with frontline and relapsed rhabdomyosarcoma

FaR-RMS is an over-arching study for children and adults with newly diagnosed and relapsed rhabdomyosarcoma (RMS), that started recruiting patients in 2019 and will end enrolling them in 2026. It is a multi-arm, multi-stage trial, involving several different questions regarding chemotherapy, local treatment, treatment at relapse or long term sequelae, among others.

The FaR-RMS trial is an overarching trial for all patients with newly diagnosed and relapsed…


Molecular profiling of non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in children, adolescents and young adults

Molecular Identification and Characterization of non-Rhabdomyosarcoma Soft Tissue Sarcoma in Kids,…